These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2672 related articles for article (PubMed ID: 18268278)

  • 21. Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte-colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trial.
    Tarella C; Rutella S; Gualandi F; Melazzini M; Scimè R; Petrini M; Moglia C; Ulla M; Omedé P; Bella VL; Corbo M; Silani V; Siciliano G; Mora G; Caponnetto C; Sabatelli M; Chiò A;
    Cytotherapy; 2010; 12(1):50-9. PubMed ID: 19878077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pluripotent and myeloid-committed CD34+ subsets in hematopoietic stem cell allografts.
    Theilgaard-Mönch K; Raaschou-Jensen K; Schjødt K; Heilmann C; Vindeløv L; Jacobsen N; Dickmeiss E
    Bone Marrow Transplant; 2003 Dec; 32(12):1125-33. PubMed ID: 14647266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In leukapheresis products from non-Hodgkin's lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression.
    Villaron EM; Almeida J; Lopez-Holgado N; Sanchez-Guijo FM; Alberca M; Blanco B; Sanchez-Abarca LI; Lopez O; Perez-Simon JA; San Miguel JF; del Cañizo MC
    Transfus Apher Sci; 2007 Oct; 37(2):145-56. PubMed ID: 17983836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of peripheral blood stem cells mobilized with granulocyte colony-stimulating factor with or without prior standard-dose chemotherapy in patients with malignancy.
    Kobayashi N; Kasai M; Masauzi N; Ogasawara M; Kiyama Y; Naohara T; Higa T; Hashino S; Tanaka J; Imamura M
    Jpn J Clin Oncol; 1995 Dec; 25(6):250-7. PubMed ID: 8523821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation.
    Kröger N; Renges H; Krüger W; Gutensohn K; Löliger C; Carrero I; Cortes L; Zander AR
    Br J Haematol; 2000 Dec; 111(3):761-5. PubMed ID: 11122135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
    Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Highly efficient gene transfer into preterm CD34 hematopoietic progenitor cells.
    Shields LE; Kiem HP; Andrews RG
    Am J Obstet Gynecol; 2000 Sep; 183(3):732-7. PubMed ID: 10992201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukapheresis products in multiple myeloma: lower tumor load after mobilization with cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) compared with G-CSF alone.
    Cremer FW; Kiel K; Wallmeier M; Haas R; Goldschmidt H; Moos M
    Exp Hematol; 1998 Sep; 26(10):969-75. PubMed ID: 9728932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization and quantitation of primitive hematopoietic progenitor cells present in peripheral blood autografts.
    Tong J; Hoffman R; Siena S; Srour EF; Bregni M; Gianni AM
    Exp Hematol; 1994 Sep; 22(10):1016-24. PubMed ID: 8088376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor.
    Gordon MY; Levicar N; Pai M; Bachellier P; Dimarakis I; Al-Allaf F; M'Hamdi H; Thalji T; Welsh JP; Marley SB; Davies J; Dazzi F; Marelli-Berg F; Tait P; Playford R; Jiao L; Jensen S; Nicholls JP; Ayav A; Nohandani M; Farzaneh F; Gaken J; Dodge R; Alison M; Apperley JF; Lechler R; Habib NA
    Stem Cells; 2006 Jul; 24(7):1822-30. PubMed ID: 16556705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of enriched CD34+ cells from healthy volunteers and those from patients treated with chemotherapy plus granulocyte colony-stimulating factor (G-CSF).
    Suzuki T; Muroi K; Tomizuka H; Amemiya Y; Miura Y
    Stem Cells; 1995 May; 13(3):273-80. PubMed ID: 7542113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of colony-forming cells, long-term culture initiating cells and CD34+ cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens.
    Bender JG; Lum L; Unverzagt KL; Lee W; Van Epps D; George S; Coon J; Ghalie R; McLeod B; Kaizer H
    Bone Marrow Transplant; 1994 Apr; 13(4):479-85. PubMed ID: 7517260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma.
    Steidl U; Fenk R; Bruns I; Neumann F; Kondakci M; Hoyer B; Gräf T; Rohr UP; Bork S; Kronenwett R; Haas R; Kobbe G
    Bone Marrow Transplant; 2005 Jan; 35(1):33-6. PubMed ID: 15531906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved granulocyte colony-stimulating factor mobilization of hemopoietic progenitors using cytokine combinations in primates.
    Larsen SR; Chng K; Battah F; Martiniello-Wilks R; Rasko JE
    Stem Cells; 2008 Nov; 26(11):2974-80. PubMed ID: 18719223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlations between hematopoietic progenitor cell counts as measured by Sysmex and CD34+ cell harvest yields following mobilization with different regimens.
    Vogel W; Kopp HG; Kanz L; Einsele H
    J Cancer Res Clin Oncol; 2002 Jul; 128(7):380-4. PubMed ID: 12136252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of peripheral blood progenitor cells mobilized by nartograstim (N-terminal replaced granulocyte colony-stimulating factor) in normal volunteers.
    Maruyama K; Tsuji K; Tanaka R; Yamada K; Kodera Y; Nakahata T
    Bone Marrow Transplant; 1998 Aug; 22(4):313-20. PubMed ID: 9722064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields.
    Sautois B; Fraipont V; Baudoux E; Fassotte MF; Hermanne JP; Jérusalem G; Bours V; Bosquée L; Schaaf-Lafontaine N; Paulus JM; Sondag D; Fillet G; Beguin Y
    Haematologica; 1999 Apr; 84(4):342-9. PubMed ID: 10190949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microarray and serial analysis of gene expression analyses identify known and novel transcripts overexpressed in hematopoietic stem cells.
    Georgantas RW; Tanadve V; Malehorn M; Heimfeld S; Chen C; Carr L; Martinez-Murillo F; Riggins G; Kowalski J; Civin CI
    Cancer Res; 2004 Jul; 64(13):4434-41. PubMed ID: 15231652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mobilization of peripheral blood stem cells by subcutaneous injections of yeast-derived granulocyte macrophage colony stimulating factor: a phase I-II study.
    Mangan K; Mullaney M; Klumpp T; Goldberg S; Macdonald J
    Stem Cells; 1993 Sep; 11(5):445-54. PubMed ID: 8241955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Filgrastim post-chemotherapy mobilizes more CD34+ cells with a different antigenic profile compared with use during steady-state hematopoiesis.
    Möhle R; Pförsich M; Fruehauf S; Witt B; Krämer A; Haas R
    Bone Marrow Transplant; 1994 Nov; 14(5):827-32. PubMed ID: 7534163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 134.